Management of neurofibromatosis type 2

Ear, Nose and Throat Journal

Volumn 78, Issue 2, 1999, Pages 91-96

  Bance, Manohar ^a,b   Ramsden, Richard T ^a  

^a Manchester Royal Infirmary ^*  (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER SUSCEPTIBILITY; HUMAN; MEDICAL SPECIALIST; NEUROFIBROMATOSIS; PATIENT CARE; RADIOSURGERY; STEREOTAXIC SURGERY; TREATMENT PLANNING;

EID: 0033048658     PISSN: 01455613     EISSN: None     Source Type: Journal    
DOI: 10.1177/014556139907800207     Document Type: Article

References (15)

1. Evans DG, Huson SM, Donnai D, et al. A genetic study of type 2 neurofibromatosis in the United Kingdom: I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity. J Med Genet 1992;29(12):841-6.
2. Evans DGR, Ramsden R, Huson SM, et al. Type 2 neurofibromatosis: The need for supraregional care. J Laryngol Otol 1993;107:401-6.
3. Hinton AE, Ramsden RT, Lye RH, Dutton JEM. Hearing preservation in acoustic neuroma surgery: How useful is it? In: Tos M, Thomsen J, eds. Acoustic Neuroma (Proceedings of First International Conference on Acoustic Neuroma, Copenhagen 1991). Amsterdam/New York: Kugler Publications, 1992:648-50.
4. Pulec JL, House WF, Britton BH, Jr., Hitselberger WE. A system of management of acoustic neuroma based on 364 cases. Trans Am Acad Ophthal Otolaryngol 1971;75:48-55.
5. Fialkow P, Sagebiel R, Gartier S., Rimoin D. Multiple cell origin of hereditary neurofibromas. N Eng J Med 1971;284:289-300.
6. Linthicum F, Brackmann D. Bilateral acoustic neuromas: A diagnostic and surgical challenge. Arch Otolaryngol 1980;106:729-33.
7. Cohen NL, Ransohoff J, Kohan D, Hoffman R. Cochlear implants in the treatment of acoustic neuromas: A treatment algorithm for bilateral acoustic neuromas (BAN). In: Tos M, Thomsen J, eds. Acoustic Neuroma (Proceedings of the First International Conference on Acoustic Neuroma Copenhagen 1991). Amsterdam/ New York: Kugler Publications, 1992:857-62.
8. nd European Skull Base Congress, Paris 1995). Amsterdam/New York: Kugler Publications, 1996:381-4.
9. National Institutes of Health Consensus Development Conference: Neurofibromatosis Conference Statement. Arch Neurol 1988;45:575-8.
10. NIH Conference Statement Neurofibromatosis 1 (von Recklinghausen's disease) and neurofibromatosis 2 (bilateral acoustic neurofibromatosis). Ann Intern Med 1990;113:39-52.
11. Noren G, Greitz D, Hirsch A, Lax I. Gamma knife surgery in acoustic neuromas. In: Tos M, Thomsen J, eds. Acoustic Neuroma (Proceedings of the First International Conference on Acoustic Neuroma, Copenhagen 1991). Amsterdam/New York: Kugler Publications, 1992.289-92.
12. Lunsford L, Flickinger J, Coffey RJ. Stereotactic gamma knife surgery. Arch Neurol 1990;47:169-175.
13. Whittaker SR, Laue P. Treatment alternatives in neurofibromatosis-2 (NF2). In: Tos M, Thomsen J, eds. Acoustic Neuroma (Proceedings of the First International Conference on Acoustic Neuroma, Copenhagen 1991). Amsterdam/New York: Kugler Publications, 1992:850-6.
14. Thomsen J, Tos M, Borgesen SE. Hydrocephalus caused by gamma knife treatment of an acoustic neuroma. In: Tos M, Thomsen J, eds. Acoustic Neuroma (Proceedings of the First International Conference on Acoustic Neuroma, Copenhagen 1991). Amsterdam/New York: Kugler Publications, 1992:311-4.
15. rd International Cochlear Implant Conference, April 4-7, 1993. Innsbruck, Austria.